Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
-
Field
-
CO2 activation and conversion techniques and exploit bio-renewable platform molecules in Newcastle University, with a specific focus on catalysis, molecular functionality creation, and production
-
University and the north east of England. Number of awards 1 Start date September 2024 Award duration The funding covers a three-year PhD. Application closing date 29th April 2024 Sponsor Newcastle University
-
between proteins, small organic molecules and water, at a fraction of the cost of quantum mechanics. They will integrate the workflows into drug discovery pipelines at Newcastle University and/or
-
physics in the field of quantum technologies? Working in collaboration with various universities (Glasgow, Heriot-Watt, Edinburgh, King’s College London, Middlesex) across UK, this PhD will investigate
-
at the School of Mathematics, Statistics and Physics at Newcastle University and will work closely with, including an opportunity to visit, our partners at the National University of Singapore. Number of awards
-
Date 21st June 2024 Sponsor EPSRC Supervisors Dr. S B Velasquez Orta and Prof. A Harvey (Newcastle University) and project supervisors Dr Leonardo Rios and Dr George Manos (UCL) Eligibility Criteria
-
to investigate fluid-structure interactions in channels. Physical modelling will be carried out in the Newcastle University Vedrana Kutija flume; state-of-the-art fully instrumented flume: glass side panels over
-
. To effectively address the climate crisis, we must transition towards a net-zero future and embrace a circular economy framework. The process industries play a significant role in greenhouse gas emissions, making
-
UKRI rate) Overview Interested in understanding the interplay between computer science and physics in the field of quantum technologies? Working in collaboration with various universities (Glasgow
-
. However, only patients with good physical fitness are candidates for systemic therapy, and even among those patients, only a minority (25-30%) benefit from it. Therefore, we need to find better treatment